L'Occitane International Owner Nearing Deal to Go Private with Funding from Blackstone, Bloomberg Reports
By Denny Jacob
--L'Occitane International owner Reinold Geiger is nearing a deal to take the skin-care company private with funding help from Blackstone, reports Bloomberg, citing people familiar with the matter.
--The alternative asset manager may provide debt financing for the buyout, according to the report. An announcement may come in the coming days, it added.
--Geiger, who is considering a 20% premium of over 26 Hong Kong dollars ($3.32) a share, has lined up financing for the deal, according to Bloomberg.
--While deliberations are at an advanced stage, no final decisions have been made and talks could still be delayed or even fall apart, according to the report.
Full story at https://www.bloomberg.com/news/articles/2024-04-09/blackstone-said-to-near-buyout-of-skin-care-company-l-occitane?srnd=homepage-americas
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 09, 2024 11:17 ET (15:17 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
How the Tokyo Stock Exchange Is Pushing for Better Capital Allocation
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting